EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Asia Pacific

Eli Lilly discontinues Ph II trials for arthritis drug

In March 2015, Hanmi signed an exclusive license agreement with the US-based drug maker to grant rights to HM71224 in a deal that could generate up to $640 million K...
Continue Reading →
news

Researchers find existing drug effective at preventing onset of type 1 diabetes

A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according...
Continue Reading →
Europe

Calcium may play a role in the development of Parkinson’s disease

Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson's disease. The inte...
Continue Reading →
news

CRF Health’s ‘Outstanding Innovation’ with Pioneering TrialConsent® Wins 2018 Clinical Informatics News Best Practices Awards

CRF Health, a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, today announced that its electronic...
Continue Reading →
Asia Pacific

US’s PCI Pharma services to acquire Australian packaging firm

The addition of PPP will mark PCI’s fifth acquisition outside of the U.S. in five years US firm PCI Pharma Services (PCI) has announced the acquisition of Australia-...
Continue Reading →
news

Novartis, Bill & Melinda Gates team up against infectious diarrheal disease

Bill & Melinda Gates Foundation will provide $6.5 million to support the development of this drug candidate for the treatment of children by the Novartis Institut...
Continue Reading →
Europe

Fraunhofer and Mologic partner on point-of-care diagnosis and antibiotic susceptibility test for UTIs

Project awarded £900K NHS development grant through SBRI Healthcare Test will allow better targeting of prescription antibiotics and address growing antimicrobia...
Continue Reading →
Asia Pacific

GE Healthcare, Tatweer Medical team up for advanced diagnostics

GE Healthcare and Medical Village will create a centralized Diagnostic Radiology Centre that will serve the entire development, providing sustainable high-quality dia...
Continue Reading →
Europe

Light-activated cancer drugs without toxic side effects: fresh insight

Future cancer drugs that are activated by light and don’t cause the toxic side-effects of current chemotherapy treatments are closer to becoming a reality, thanks to ...
Continue Reading →
Europe

Horizon Discovery enters into license agreement with US immuno-oncology company

Horizon out-licenses proprietary cell line and Helitron transposon gene editing technologies, demonstrating Horizon’s ability to generate revenues from internally ...
Continue Reading →
Quotient